The FDA Didn't Approve MDMA. Is the Medical System Ready for Any Psychedelic?
Briefly

FDA rejected MDMA for PTSD therapy, demands more data. Concerns arise over U.S. readiness for legal psychedelics in healthcare.
Clinical trials show promising results for MDMA-assisted PTSD therapy. 71% no longer meet PTSD criteria after treatment, urging FDA to reconsider.
FDA's decision challenges psychedelics' place in U.S. healthcare. Industry faces workforce shortage, insurance, safety, and illegality concerns.
Read at time.com
[
|
]